2022 New Zealand Molecular Diagnostics Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides molecular diagnostics market shares.
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
iasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics/Carlyle Group
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
iasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics/Carlyle Group
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
2017 New Zealand Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities
US$ 3,375.00
January 2017
517 pages
2021 New Zealand Blood Banking Market Perspective-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers Review
US$ 2,850.00
June 2021
400 pages
2018 New Zealand Clinical Chemistry Reagents and Analyzers Market Analysis: Supplier Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 3,750.00
March 2018
517 pages
2020-2025 New Zealand Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
US$ 1,450.00
December 2020
-
2021 New Zealand Transfusion Diagnostics Market Assessment-Immunohematology and NAT Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 1,850.00
February 2021
400 pages
